Kelley Drye & Warren LLP has announced that the following attorneys, who were formerly associates, have become members of the firm. They include:
- James E. Nealon, a partner in the Litigation Department in Stamford, CT. Mr. Nealon's practice focuses on complex commercial and business litigation, including securities law and broker-dealer arbitrations, class action defense, contract and employment disputes, fraud, antitrust, unfair competition, intellectual property and bankruptcy.
- Neil F. O'Donnell, a partner in the Corporate Department in Washington, DC. Mr. O'Donnell's practice focuses on a variety of corporate and commercial finance transactions, including mergers, acquisitions and divestitures, commercial lending and corporate finance, venture capital and private equity, as well as project and structured financings for financial institutions, equity investors, developers and other clients.
- M. David Short, a partner in the Litigation Department in Chicago. Mr. Short's practice focuses on civil litigation, with a strong emphasis on defending self-insured entities against product liability claims.
- Robert I. Steiner, a partner in the Litigation Department in New York City. Mr. Steiner's practice focuses on commercial, securities, appellate and employment litigation.
- Troy D. Reynolds, special counsel in the Corporate Department in Washington, DC. Mr. Reynolds has in-depth experience in corporate transactional matters, representing technology and telecommunications clients in the United States and internationally.
Kelley Drye has also announced that Steven J. Moore will join the firm as partner in the Intellectual Property Practice & Technology Practice Group. He will practice in Kelley Drye's Stamford, CT office.
Dr. Moore has extensive experience in a variety of IP-related issues, including high-stakes patent litigation and complex transactional matters. Specifically, he has expertise in the transfer of intellectual property in the context of mergers and acquisitions, patent portfolio assessment or investment banks and venture capital firms, intellectual property transactional due diligence in the context of private placements and initial public offerings, intellectual property licensing, and intellectual property opinions, including patent infringement and validity analyses and freedom-to-operate opinions. He also has experience in patent counseling and procurement, and has dealt with various India-based pharmaceutical companies in both Mumbai and New Delhi.